ClariVest Asset Management’s Vir Biotechnology VIR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-77,054
| Closed | -$1.89M | – | 850 |
|
2023
Q2 | $1.89M | Sell |
77,054
-11,678
| -13% | -$287K | 0.09% | 138 |
|
2023
Q1 | $2.06M | Buy |
88,732
+52
| +0.1% | +$1.21K | 0.09% | 170 |
|
2022
Q4 | $2.25M | Sell |
88,680
-241
| -0.3% | -$6.1K | 0.11% | 149 |
|
2022
Q3 | $1.72M | Sell |
88,921
-17,296
| -16% | -$334K | 0.08% | 179 |
|
2022
Q2 | $2.71M | Sell |
106,217
-37,500
| -26% | -$955K | 0.12% | 149 |
|
2022
Q1 | $3.7M | Buy |
143,717
+46,574
| +48% | +$1.2M | 0.15% | 148 |
|
2021
Q4 | $4.07M | Buy |
+97,143
| New | +$4.07M | 0.13% | 156 |
|
2021
Q3 | – | Sell |
-8,896
| Closed | -$420K | – | 831 |
|
2021
Q2 | $420K | Buy |
8,896
+3
| +0% | +$142 | 0.01% | 447 |
|
2021
Q1 | $456K | Sell |
8,893
-2,768
| -24% | -$142K | 0.02% | 425 |
|
2020
Q4 | $311K | Sell |
11,661
-16,033
| -58% | -$428K | 0.01% | 459 |
|
2020
Q3 | $951K | Buy |
+27,694
| New | +$951K | 0.03% | 307 |
|